![Matthew M. Loar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew M. Loar
Corporate Officer/Principal chez
The American Institute of Certified Public Accountants
Profil
Matthew M.
Loar currently works at The American Institute of Certified Public Accountants, as Member.
Mr. Loar also formerly worked at Neurobiological Technologies, Inc., as Director, Chief Executive & Financial Officer from 2012 to 2014, Transcept Pharma, Inc., as Independent Director, Oncotelic Therapeutics, Inc., as Chief Financial Officer & Secretary in 2019, Genelabs Technologies, Inc., as Chief Financial Officer from 1995 to 2006, KineMed, Inc., as Chief Financial Officer from 2014 to 2015, Virolab, Inc., as Chief Financial Officer from 2011 to 2012, and Osteologix Holdings Plc, as Chief Financial Officer & Secretary from 2006 to 2008.
Mr. Loar received his undergraduate degree from the University of California, Berkeley.
Postes actifs de Matthew M. Loar
| Sociétés | Poste | Début |
|---|---|---|
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Anciens postes connus de Matthew M. Loar
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Directeur Financier/CFO | 30/06/2019 |
| KINEMED INC | Directeur Financier/CFO | 01/07/2015 |
Virolab, Inc.
 Virolab, Inc. Financial ConglomeratesFinance Operated as a development stage company which engaged in the development and commercialization of products to improve human healthcare | Directeur Financier/CFO | 01/08/2012 |
| OSTEOLOGIX HOLDINGS PLC | Directeur Financier/CFO | 01/04/2008 |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Directeur Financier/CFO | 01/09/2006 |
Formation de Matthew M. Loar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Health Technology |
Neurobiological Technologies, Inc.
 Neurobiological Technologies, Inc. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
KineMed, Inc.
 KineMed, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biomarker platform technology | Commercial Services |
Virolab, Inc.
Virolab, Inc. Financial ConglomeratesFinance Operated as a development stage company which engaged in the development and commercialization of products to improve human healthcare | Finance |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Osteologix Holdings Plc
 Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Operates as an investment holding company with interest in development of pharmaceuticals | Health Technology |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
